acetylglucosamine has been researched along with Encephalitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandt, AU; Cordon, A; Demetriou, M; Dennis, JW; Hayama, KL; Kuhle, J; Newton, BL; Pawling, J; Sy, M; Yu, Z | 1 |
| Abe, K; Deguchi, K; Hishikawa, N; Kono, S; Kurata, T; Omote, Y; Sato, K; Yamashita, T | 1 |
2 other study(ies) available for acetylglucosamine and Encephalitis
| Article | Year |
|---|---|
N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial.
Topics: Acetylglucosamine; Animals; Cytokines; Encephalitis; Glatiramer Acetate; Humans; Inflammation; Interleukin-17; Interleukin-6; Mice; Multiple Sclerosis | 2023 |
Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke.
Topics: Acetylglucosamine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Carrier Proteins; Cerebral Cortex; Collagen Type IV; Disease Models, Animal; Encephalitis; Glial Fibrillary Acidic Protein; Hypertension; Infarction, Middle Cerebral Artery; Inflammasomes; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Inbred SHR; Telmisartan; Time Factors | 2015 |